<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a group of closely related disorders characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> cytopenias with cellular marrow, poor prognosis and refractoriness to treatment </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 101 consecutive cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosed over a 7-year period </plain></SENT>
<SENT sid="2" pm="."><plain>Peripheral blood (PB) and bone marrow (BM) samples were reviewed and classified according to the proposals of the French-American-British (FAB) cooperative group for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The combined analysis of the initial laboratory features and qualitative <z:e sem="disease" ids="C0850715" disease_type="Disease or Syndrome" abbrv="">haematological abnormalities</z:e> readily allowed the distinction between the different subgroups </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-two of 79 cases (40.5%) evolved towards other diseases, frequently <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (24/79, 30%), or transformed into other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (7/79, 9%) </plain></SENT>
<SENT sid="5" pm="."><plain>In five cases, initially classified as refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA) or refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ring sideroblasts (<z:mp ids='MP_0011356'>RAS</z:mp>), a transitory change to another type of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>--two <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemias</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), two refractory <z:hpo ids='HP_0001903'>anaemias</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and one refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts 'in transformation' (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t)--was observed before the evolution towards <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>This provides a new link between <z:hpo ids='HP_0000001'>all</z:hpo> these syndromes and increases the number of transitions to other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Overall prognosis was very poor, with differences between subgroups </plain></SENT>
<SENT sid="8" pm="."><plain>RA had the best prognosis whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t had the worst one </plain></SENT>
<SENT sid="9" pm="."><plain>This study shows that the FAB classification is readily usable and defines well-characterized subgroups of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, although there are frequent transitional forms, and as the natural history of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> unfolds they may convert into another </plain></SENT>
<SENT sid="10" pm="."><plain>The actual poor prognosis and the frequent evolution towards <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> makes necessary to investigate new methods of treatment for these disorders </plain></SENT>
</text></document>